CL
FOLD

Choreo LLC’s Amicus Therapeutics FOLD Stock Holding History

Choreo LLC’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,046
Closed -$357K – 1648
2025
Q4 		$357K Buy
25,046
+2,390
+11% +$23.5K ﹤0.01% 1112
2025
Q3 		$179K Buy
22,656
+6,586
+41% +$46.9K ﹤0.01% 1470
2025
Q2 		$92.1K Buy
+16,070
New +$104K ﹤0.01% 1469
2025
Q1 		– Sell
-10,898
Closed -$103K – 1516
2024
Q4 		$103K Buy
+10,898
New +$113K ﹤0.01% 1497

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Choreo LLC's FOLD Position: Q1 2026 in Review

Choreo LLC sold out of Amicus Therapeutics (FOLD) in Q1 2026, closing a stake of 25,046 shares — an estimated $357K sold.

Choreo LLC first reported a position in FOLD in Q4 2024 and held it in 4 quarters. The position peaked at $357K in Q4 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Choreo LLC reported no remaining Amicus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Choreo LLC sold 25,046 Amicus Therapeutics shares in Q1 2026, an estimated $357K.
  • Choreo LLC first reported a position in Amicus Therapeutics in Q4 2024 and held it in 4 quarters.
  • Choreo LLC's Amicus Therapeutics position peaked at $357K in Q4 2025.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.